Pacira BioSciences' (PCRX) CEO Dave Stack on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/04/22
Pacira (PCRX) to Report Q1 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 04/26/22
Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/05/22
Pacira BioSciences to Participate in Fireside Chat at the Barclays Global Healthcare ConferenceGlobeNewsWire • 03/09/22
Pacira BioSciences, Inc. (PCRX) CEO Dave Stack on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/24/22
Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial ResultsGlobeNewsWire • 02/24/22
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $37.3 Million for January 2022GlobeNewsWire • 02/15/22
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021GlobeNewsWire • 12/07/21
Pacira (PCRX) Down 4.5% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 12/03/21
Pacira BioSciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/23/21
Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain ManagementGlobeNewsWire • 11/19/21
Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021GlobeNewsWire • 11/09/21